Sandhill Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-54,528
Closed -$12.2M 74
2019
Q1
$12.2M Buy
54,528
+2,798
+5% +$578K 1.7% 30
2018
Q4
$9.62M Buy
51,730
+1,812
+4% +$371K 1.59% 30
2018
Q3
$12.5M Sell
49,918
-10,534
-17% -$2.56M 1.85% 29
2018
Q2
$13.2M Sell
60,452
-32,286
-35% -$6.65M 2.08% 25
2018
Q1
$17.7M Buy
92,738
+3,220
+4% +$594K 2.91% 17
2017
Q4
$14M Buy
89,518
+1,726
+2% +$272K 2.49% 21
2017
Q3
$13.7M Buy
87,792
+438
+0.5% +$69.2K 2.66% 21
2017
Q2
$14.1M Sell
87,354
-20,699
-19% -$3.36M 2.98% 19
2017
Q1
$16.7M Sell
108,053
-24,221
-18% -$3.34M 3.91% 10
2016
Q4
$15.5M Buy
132,274
+2,493
+2% +$284K 4.26% 7
2016
Q3
$14.6M Sell
129,781
-1,955
-1% -$206K 4.4% 5
2016
Q2
$12.2M Buy
131,736
+2,655
+2% +$228K 3.83% 11
2016
Q1
$10.1M Sell
129,081
-74
-0.1% -$5.33K 3.32% 18
2015
Q4
$9.42M Buy
+129,155
New +$9.21M 3% 21

Other funds holding IDXX

Sandhill Capital Partners's IDXX Position: Q2 2019 in Review

Sandhill Capital Partners sold out of Idexx Laboratories (IDXX) in Q2 2019, closing a stake of 54,528 shares — an estimated $12.2M sold.

Sandhill Capital Partners first reported a position in IDXX in Q4 2015 and held it in 14 quarters. The position peaked at $17.7M in Q1 2018. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2019.

  • Sandhill Capital Partners reported no remaining Idexx Laboratories position as of Q2 2019 after selling out during the quarter.
  • Sandhill Capital Partners sold 54,528 Idexx Laboratories shares in Q2 2019, an estimated $12.2M.
  • Sandhill Capital Partners first reported a position in Idexx Laboratories in Q4 2015 and held it in 14 quarters.
  • Sandhill Capital Partners's Idexx Laboratories position peaked at $17.7M in Q1 2018.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2019.

Based on Sandhill Capital Partners's 13F filing for Q2 2019, filed 13 Aug 2019.